Microneedling Opens Door for Rosacea Relief


Microneedling may offer promise as a treatment for clients with rosacea, according to research presented at the American Academy of Dermatology Annual Meeting.

Twenty women with erythematotelangiectatic rosacea ages 27–65 were studied, divided into two treatment groups. Both groups were treated every 15 days over four sessions; the first was treated with a wet dressing infused with tranexamic acid solution for 20 minutes, while the second group added simultaneous microneedling with a tranexamic acid solution topical application. Tranexamic acid is an antifibrinolytic medication, often used to improve clotting for women with heavy menstrual cycles and to prevent major blood loss after surgery, trauma, tooth extraction, etc.

Both groups showed improvement, as assessed by Investigator Global Assessment of Rosacea Severity Score (IGA-RSS). However, microneedling proved more effective, with patients showing an improvement of 3 units, in comparison to the 2 units of IGA-RSS seen in the other group. Clinical photos and dermoscopy were also used to assess improvment.

The researchers were confident that the treatment shows promise for inexpensive and quick treatment of the vascular net and erythema associated with rosacea.

More in MedSpa